+91 9860854331
sales@mdatapartners.com

Drug Data

Symbicort Drug Total Revenue (Asthma, COPD) - Global - AstraZeneca

(in million U.S. dollars)

Description

AstraZeneca Company is a global biopharmaceutical company.

  • Last Updated Date : 26 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : AstraZeneca (ANNUAL REPORT FORM 10-K)
  • Competitors : GSK
Pulmicort Drug Total Revenue (Asthma, COPD) - Global - AstraZeneca

(in million U.S. dollars)

Description

AstraZeneca Company is a global biopharmaceutical company.

  • Last Updated Date : 26 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : AstraZeneca (ANNUAL REPORT FORM 10-K)
  • Competitors : GSK
Breztri/Trixeo Drug Total Revenue (COPD) - Global - AstraZeneca

(in million U.S. dollars)

Description

AstraZeneca Company is a global biopharmaceutical company.

  • Last Updated Date : 26 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : AstraZeneca (ANNUAL REPORT FORM 10-K)
  • Competitors : GSK
Trelegy Ellipta Drug Total Revenue (Asthma,COPD) - Global - GSK

(in million Pound Sterling)

Description

GSK Company is a global biopharmaceutical company.

  • Last Updated Date : 26 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : GSK (ANNUAL REPORT FORM 10-K)
  • Competitors : AstraZeneca
Relvar/Breo Ellipta Drug Total Revenue (Asthma,COPD) - Global - GSK

(in million Pound Sterling)

Description

GSK Company is a global biopharmaceutical company.

  • Last Updated Date : 26 Jul 2025
  • Study Period : 2018-2024
  • Category : Drug Data
  • Sources : GSK (ANNUAL REPORT FORM 10-K)
  • Competitors : AstraZeneca

Other Statistical Reports

Immunology

Oncology

Cardiology

Dermatology And Aesthetics

Rare Disease

Infectious Diseases And Vaccines

Neuroscience

Ophthalmology

Metabolism

Other Internal Medicine

Have questions about how our healthcare intelligence solutions can empower your organization?

Contact Us
up